APA (7th ed.) Citation

Wang, R., Yang, Q., Luo, R., Peng, Y., Dai, S., Zhang, X., . . . Zheng, Y. (2014). Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Wang, Rui-Rui, et al. Azvudine, a Novel Nucleoside Reverse Transcriptase Inhibitor Showed Good Drug Combination Features and Better Inhibition on Drug-resistant Strains than Lamivudine in Vitro. Public Library of Science (PLoS), 2014.

MLA (8th ed.) Citation

Wang, Rui-Rui, et al. Azvudine, a Novel Nucleoside Reverse Transcriptase Inhibitor Showed Good Drug Combination Features and Better Inhibition on Drug-resistant Strains than Lamivudine in Vitro. Public Library of Science (PLoS), 2014.